Boryung’s new antihypertensive drug published in peer journal

Boryung Pharmaceutical Co. says that the efficacy and safety of its Kanarb (fimasartan), a homegrown antihypertensive drug, are fully demonstrated in the global scientific arena.

The results of Phase III study of Kanarb, published in the latest issue of the international scientific journal Clinical Therapeutics (Volume 34, Number 3,2012), showed better antihypertensive effect of fimasartan 6...